Эректильная дисфункция и ожирение

1. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. WHO: Geneva, 1997, June 3-5.
2. Kaplan H.S. The Evaluation of Sexual Disorders: Psychological and Medical Aspects. New York: Brunner/Mazel; 1983.
3. Lue T., Basson R., Rosen R. et al. Sexual medicine. Sexual dysfunction in men and women. Second international consultation on sexual dysfunction. Paris: Health Publication 2004.
4. Дедов И.И., Мельниченко Г.А. Ожирение. М: МИА 2004: 185-188.
5. Wagner G., Saenz de Tejada I. Update in male erectile dysfunction. BMJ 1998; 316: 678-682.
6. Мазо Е.Б., Гамидов С.И., Иремашвили В.В. Эректильная дисфункция. М: МИА 2008: 5-14.
7. Shabsigh R., Perelman M.A., Lockhart D.C. et al. Health issue of men: prevalence and correlates of erectile dysfunction. J Urol 2005; 174: 662-667.
8. http://www.iotf.org/popout.asp?linkto=http:www.iotf.org/media/globalprev.htm.
9. Feldman H.A., Johannes C.B., Derby C.A. et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 2000; 30: 328-338.
10. Derby C.A., Mohr B.A., Goldstein I. et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302-306.
11. Shiri R., Koskimaki J., Hakama M. et al. Effect of life-style factors on incidence of erectile dysfunction. Int J Impot Res 2004; 16: 389-394.
12. Fung M.M., Bettencourt R., Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol 2004; 43: 1405-1411.
13. Blanker M.H., Bohnen A.M., Groeneveld F.P. et al. Correlates for erectile and ejaculatory dysfunction on older Dutch men: a community-based study. J Am Geriatr Soc 2001; 49: 436-442.
14. Bacon C.G., Mittleman M.A., Kawachi I. et al. Sexual function in men older than 50 years of age: results form the health professionals follow-up study. Ann Intern Med 2003; 139: 161-168.
15. Feldman H.A., Goldstein I., Hatzichristou D.G. et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
16. Chung W.S., Sohn J.H., Park Y.Y. Is obesity an underlying factor in erectile dysfunction? Eur Urol 1999; 36: 68-70.
17. Bray G.A. Medical consequences of obesity. J Clin Endocrinol Metab 1989; 2583-2589.
18. Esposito K., Giugliano F., Di Palo C. et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004; 291: 2978-2984.
19. Esposito K., Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004; 14: 228-232.
20. Chudek J., Wiecek A. Adipose tissue, inflammation and endothelial dysfunction. Pharmacol Rep 2006; 81-88.
21. Pietiläinen K.H., Kannisto K., Korsheninnikova E. et al. Acquired obesity increases CD and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins. J Clin Endocrinol Metab 2006; 91: 2776-2781.
22. Pietiläinen K.H., Bergholm R., Rissanen A. et al. Effects of acquired obesity on endothelial function in monozygotic twins. Obesity 2006; 14: 826-837.
23. Sowers J.R. Endocrine functions of adipose tissue: focus on adiponectin. Clin Cornerstone 2008; 9: 32-40.
24. Giugliano F., Esposito K., Di Palo C. et al. Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokines levels in obese men. J Endocrinol Invest 2004; 27: 665-669.
25. Diamant M., Tushuizen M.E., Sturk A., Nieuwland R. Cellular microparticles: new players in the field of vascular disease. Eur J Clin Invest 2004; 34: 392-401.
26. Ferreira A.C., Peter A.A., Mendez A.J. et al. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation 2004; 110: 3599-3603.
27. Sabatier F., Darmon P., Hugel B. et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002; 51: 2840-2845.
28. Bernal-Mizrachi L., Jy W., Fierro C. et al. Endothelial microparticles correlate with high-risk angiographic lesions in acute syndrome. Int J Cardiol 2004; 97: 439-446.
29. Koga H., Sugiyama S., Kugiyama K. et al. Elevated levels of VE-Cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005; 45: 1622-1630.
30. Werner N., Wassmann S., Ahlers P. et al. Circulating CD31+/Annessin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 112-116.
31. Brodsky S.V., Zhang F., Nasjletti A., Goligorsky M.S. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Circ Heart Physiol 2004; 286: H1910-H1915.
32. Cheitlin M.D. Erectile dysfunction. The earliest sign of generalized vascular disease? J Am Coll Cardiol 2004; 43: 185-186.
33. Blumentals W.A., Gomez-Caminero A., Joo S., Vannapagari V. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Int J Imp Res 2004; 16: 350-353.
34. Гамидов C.И., Овчинников Р.И., Попова А.Ю. Эректильная дисфункция у больных с метаболическим синдромом. Врач 2012; 6: 40-44.
35. Калинченко С.Ю., Козлов Г.И. Эректильная дисфункция у больных сахарным диабетом. Диагностика. Дифферен­циальная диагностика. Лечение. Пособие для врачей. М 2003.
36. Hermans M.P., Ahn S.A., Rousseau M.F. Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes. Diabetes Metab 2009; 35 (6): 484-489.
37. Klein R., Klein B.E., Lee K.E. et al. Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 1996; 19: 135-141.
38. El-Sakka A.l., Tayeb K.A. Erectile dysfunction risk factors in noninsulin dependent diabetic Saudi patients. J Urol 2003; 169: 1043-1047.
39. Есауленко Д.И., Роживанов Р.В., Калинченко С.Ю. Эрек­тильная дисфункция как одно из проявлений декомпенсации сахарного диабета. Сахарный диабет 2005; 1: 32-33.
40. Seidell J.C., Bjorntorp P., Sjostrom L. et al. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990; 39 (9): 897-901.
41. Jensen T.K., Andersson A.M., Jorgensen N. et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 2004; 82 (4): 863-870.
42. Gapstur S.M., Gann P.H., Kopp P. et al. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 2002; 11 (10 Pt 1): 1041-1047.
43. Allen N.E., Appleby P.N., Davey G.K., Key T.J. Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men. Cancer Causes Control 2002; 13 (4): 353-363.
44. Svartberg J., von Muhlen D., Schirmer H. et al. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso Study. Eur J Endocrinol 2004; 150 (1): 65-71.
45. Svartberg J., von Muhlen D., Sundsfjord J. et al. Waist circumference and testosterone levels in community dwelling men. The Tromso Study Eur J Epidemiol 2004; 19 (7): 657-663.
46. Pasquali R., Casimirri F., Cantobelli S. et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991; 40 (1): 101-104.
47. Laaksonen D.E., Niskanen L., Punnonen K. et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003; 149 (6): 601-608.
48. Kalyani R.R., Dobs A.S. Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes 2007; 14 (3): 226-234.
49. Corona G., Mannucci E., Petrone L. et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res 2006; 18 (2): 190-197.
50. Corona G., Mannucci E., Schulman C. et al. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 2006; 50 (3): 595-604.
51. Corona G., Mannucci E., Petrone L. et al. NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med 2007; 4: 1038-1045.
52. Tsao C.W., Hsu C.Y., Chou Y.C. et al. Is obesity correlated with sexual function in young men? J Androl 2009; 32 (4): 275-279.
53. Isidori A.M., Caprio M., Strollo F. et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 1999; 84 (10): 3673-3680.
54. Hammoud A.O., Gibson M., Peterson C.M. et al. Obesity and male reproductive potential. J Androl 2006; 27 (5): 619-626.
55. Kokkoris P., Pi-Sunyer F.X. Obesity and endocrine disease. Endocrinol Metab Clin North Am 2003; 32 (4): 895-914.
56. Попова А.Ю. Клиническая эффективность лечения эректильной дисфункции у больных ожирением: Автореф. дис. … канд. мед наук. М 2007; 1-20.
57. Rosmond R., Wallerius S., Wanger P. et al. A 5 year follow-up study of disease incidence in men with an abnormal hormone pattern. J Intern Med 2003; 254: 386-390.
58. Gunduz M.I., Gumus B.H., Sekuri C. Relationship between metabolic syndrome and erectile dysfunction. Asian J Androl 2004; 6: 355-358.

________________________________________________

A.S. AMETOV, M.V. STELMAKH

Department of Endocrinology and Diabetology Russian Medical Academy of Postgraduate Education, Moscow